The extracellular matrix and cytokines regulate microglial integrin expression and activation.

Area of Science:

• Neuroimmunology
• Cellular Biology
• Molecular Biology

Background:

• Microglia are key immune cells in the central nervous system (CNS).
• Microglial activation involves changes in morphology and expression of cell adhesion molecules, including integrins.
• Understanding regulators of microglial activation is crucial for CNS health and disease.

Purpose of the Study:

• To investigate the roles of specific cytokines and extracellular matrix (ECM) substrates in regulating microglial activation.
• To determine how these factors influence the expression of major histocompatibility complex (MHC) and integrin molecules on microglia.

Main Methods:

• Microglial cultures were treated with individual cytokines (TNF, IFN-alpha, TGF-beta1) and ECM substrates (fibronectin, vitronectin, laminin).
• Cell surface expression of MHC and integrins (e.g., alpha(4)beta(1), alpha(5)beta(1), Mac-1) was quantified using flow cytometry.
• Microglial morphology was assessed to evaluate activation status.

Main Results:

• Pro-inflammatory cytokines TNF and IFN-alpha promoted microglial activation, increasing MHC class I and integrin expression (alpha(4)beta(1), Mac-1).
• Transforming growth factor-beta1 (TGF-beta1) suppressed microglial activation and integrin expression, dominating over other cytokines.
• Fibronectin and vitronectin, but not laminin, induced microglial activation and increased expression of alpha(4)beta(1), alpha(5)beta(1), and Mac-1 integrins, effects not inhibited by TGF-beta1.

Conclusions:

• Both cytokines and ECM components significantly regulate microglial activation and integrin expression.
• Increased availability of fibronectin or vitronectin in the CNS, potentially due to blood-brain barrier breakdown or pathological conditions, may drive microglial activation and integrin upregulation.